Amyotrophic Lateral Sclerosis: Pathophysiology, Diagnosis and Management

ISSN： 1172-7047

Source： CNS Drugs, Vol.25, Iss.1, 2011-01, pp. : 1-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Amyotrophic Lateral Sclerosis

By Corcia Philippe Meininger Vincent

Drugs, Vol. 68, Iss. 8, 2008-01 ,pp. : 1037-1048

Adis International

Access to resources Recommend Favorite

Diagnosis, Pathogenesis and Therapeutic Targets in Amyotrophic Lateral Sclerosis

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 6, 2010-12 ,pp. : 764-778

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Creatine in the Management of Amyotrophic Lateral Sclerosis and Other Neurodegenerative Disorders

By Amy Cameron Ellis Jeffrey Rosenfeld

CNS Drugs, Vol. 18, Iss. 14, 2004-01 ,pp. : 967-980

Adis International

Access to resources Recommend Favorite

Depression and Anxiety in Individuals with Amyotrophic Lateral Sclerosis: Epidemiology and Management

By Kurt Anja

CNS Drugs, Vol. 21, Iss. 4, 2007-01 ,pp. : 279-291

Adis International

Access to resources Recommend Favorite

Emerging drugs for amyotrophic lateral sclerosis

By Habib Ali Aamer Mitsumoto Hiroshi

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 3, 2011-09 ,pp. : 537-558

Informa Healthcare

Access to resources Recommend Favorite